Choosing the right screening library could make or break a drug discovery program in its early phases. The ideal screening library is comprised of compounds that are structurally and functionally diverse and demonstrate suitable pharmacokinetic properties while excluding potentially problematic structures.
The Maybridge screening collection is widely acknowledged as a critical tool in screening campaigns, containing over 51,000 organic compounds manufactured by Thermo Fisher Scientific. These are individually designed compounds produced by innovative synthetic techniques, based on over 45 years of experience in heterocyclic chemistry.
Our screening libraries are designed to increase the odds of positive results while optimizing cost, time, and effort spent per project. Learn more about the Maybridge screening collection below.